890475007: Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Hepatitis C virus protein NS5A inhibitor-containing product\Ombitasvir-containing product\Ombitasvir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Hepatitis C virus protein NS5A inhibitor-containing product\Ombitasvir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Hepatitis C virus protein NS5A inhibitor-containing product\Ombitasvir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Protease inhibitor-containing product\Hepatitis C virus NS3/4A protease inhibitor-containing product\Paritaprevir-containing product\Paritaprevir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Protease inhibitor-containing product\Hepatitis C virus NS3/4A protease inhibitor-containing product\Paritaprevir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Protease inhibitor-containing product\Hepatitis C virus NS3/4A protease inhibitor-containing product\Paritaprevir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Protease inhibitor-containing product\Ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Protease inhibitor-containing product\Ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Protease inhibitor-containing product\Ritonavir-containing product\Ritonavir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Carbamate-containing product\Ritonavir-containing product\Ritonavir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Ritonavir-containing product\Ritonavir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Medicinal product categorised by therapeutic role\Antiviral agent\...
• \Antiretroviral agent\Ritonavir-containing product\...
• \Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Ritonavir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Ombitasvir-containing product\Ombitasvir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Ombitasvir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Ombitasvir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Paritaprevir-containing product\Paritaprevir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Paritaprevir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir and paritaprevir and ritonavir only product\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Paritaprevir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Product manufactured as oral dose form\Ombitasvir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Product manufactured as oral dose form\Paritaprevir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet
• \Product manufactured as oral dose form\Ritonavir-containing product in oral dose form\Ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form\Ombitasvir and paritaprevir and ritonavir only product in oral dose form\Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet

Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4012778018	Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
4164992019	Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start